ArticleJournal of frailty, sarcopenia and falls2025
Assessing SARCopenia with ecHOgraphy in Community-Dwelling Older Adults: A Validation Study (SARCHO).
Article in Journal of frailty, sarcopenia and falls, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unseen and untreated: implementing sarcopenic obesity care in Nordic general practice.Frontiers in aging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To prospectively evaluate the diagnostic accuracy of the sarcopenia echography (SARCHO) point-of-care ultrasound protocol for diagnosing sarcopenia, in accordance with the European Working Group on Sarcopenia in Older People 2. Methods: This study was conducted as a single-center prospective, feasibility diagnostic accuracy study among referred patients for falls assessment. They underwent an assessment for sarcopenia according to the EWGSOP2 criteria. Participants were subjected to physical testing: 30-second chair stand test, short physical performance battery (SPPB), timed-up and go (TUG) test, and imaging procedures using DXA(gold standard) and SARCHO. Results: 24 participants (15 women) with a mean age of 81 (± 5.2) years were included. Nine participants were classified as sarcopenic by DXA and physical testing, whereas seven participants were classified as sarcopenic by SARCHO and physical testing, according to the EWGSOP2 criteria. SARCHO showed a diagnostic accuracy of 91.7% (95% CI: 81.9 - 97.2). When assessing the muscle architectural components, sarcopenic individuals showed lower muscle thickness, cross-sectional area, and pennation angle and a higher shear-wave kiloPascal value indicating higher degree of muscle stiffness. Conclusion: The SARCHO protocol is a promising point-of-care, bedside tool with high diagnostic accuracy, providing a valuable standardized and evidence-based approach for assessing sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.